Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol (Q31088061)

16 August 2017

1 reference

8 February 2021

1 reference

PubMed publication ID

27130164

title

Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol (English)

1 reference

16 August 2017

venous thromboembolism

1 reference

8 February 2021

1 reference

18 November 2019

1 reference

12 December 2020

1 reference

8 February 2021

1 reference

19

Gordon Guyatt

1 reference

16 August 2017

Maura Marcucci

29

0 references

Simon Noble

Simon Noble

8

0 references

George Bozas

George Bozas

30

0 references

Robert D McBane

Robert McBane

36

0 references

Matthias Briel

Matthias Briel

4

0 references

Ivan D. Florez

Ivan Florez

25

0 references

Alfonso Iorio

Alfonso Iorio

12

0 references

Elie A Akl

39

Elie A Akl

1 reference

16 August 2017

18

Jan Brozek

1 reference

16 August 2017

1

Holger J Schünemann

1 reference

16 August 2017

28

Walter Ageno

1 reference

16 August 2017

13

Joseph Beyene

1 reference

16 August 2017

17

Melissa Brouwers

1 reference

16 August 2017

15

Ignacio Neumann

1 reference

16 August 2017

22

Nancy Santesso

1 reference

16 August 2017

24

Tejan Baldeh

1 reference

16 August 2017

2

Matthew Ventresca

1 reference

16 August 2017

3

Mark Crowther

1 reference

16 August 2017

7

Gary Lyman

1 reference

16 August 2017

9

Fergus Macbeth

1 reference

16 August 2017

11

Marcello DiNisio

1 reference

16 August 2017

23

Michael Streiff

1 reference

16 August 2017

26

Ozlem Gurunlu Alma

1 reference

16 August 2017

27

Ziad Solh

1 reference

16 August 2017

31

Gilbert Zulian

1 reference

16 August 2017

32

Anthony Maraveyas

1 reference

16 August 2017

38

Uwe Pelzer

1 reference

IPDMA heparin use in cancer patients research group

16 August 2017

40

IPDMA heparin use in cancer patients research group

1 reference

16 August 2017

Qi Zhou

5

1 reference

16 August 2017

David Garcia

6

1 reference

16 August 2017

Gareth Griffiths

10

1 reference

16 August 2017

Lawrance Mbuagbaw

14

1 reference

16 August 2017

Nick Van Es

16

1 reference

16 August 2017

Mark Levine

20

1 reference

16 August 2017

Stephan Moll

21

1 reference

16 August 2017

Bernard Lebeau

33

1 reference

16 August 2017

Harry Buller

34

1 reference

16 August 2017

Jessica Evans

35

1 reference

16 August 2017

Suzanne Bleker

37

1 reference

16 August 2017

language of work or name

1 reference

29 April 2016

7 references

16 August 2017

22 March 2019

3 April 2019

17 June 2019

18 November 2019

12 December 2020

8 February 2021

5 references

16 August 2017

17 June 2019

18 November 2019

12 December 2020

8 February 2021

6

1 reference

16 August 2017

4

1 reference

16 August 2017

e010569

1 reference

Creative Commons Attribution-NonCommercial

16 August 2017

6 references

22 March 2019

3 April 2019

17 June 2019

18 November 2019

12 December 2020

8 February 2021

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Parenteral anticoagulation in ambulatory patients with cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Heparin as an inhibitor of cancer progression.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Development and validation of a predictive model for chemotherapy-associated thrombosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Subgroup analysis and other (mis)uses of baseline data in clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Electronic alerts to prevent venous thromboembolism among hospitalized patients.

28 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Can low-molecular-weight heparins improve outcome in patients with cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Heparin-induced thrombocytopenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

The effect of low molecular weight heparin on survival in patients with advanced malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

A multilevel model framework for meta-analysis of clinical trials with binary outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Prediction of venous thromboembolism in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010569

Nursing assessment of deep vein thrombosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853971

Multilevel models for meta-analysis, and their application to absolute risk differences

25 November 2018

1 reference

12 December 2020

Low molecular weight heparin

1 reference

12 December 2020

Routine heparin for patients with cancer? One answer, more questions

1 reference

12 December 2020

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

1 reference

12 December 2020

10.1136/BMJOPEN-2015-010569

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

27130164

1 reference